Menu Close

Comparison between fibromyalgia, polymyalgia rheumatica, myositis and rheumatoid arthritis

Clinical presentation for fibromyalgia

  • Typical patient is a female between 30 and 50 years of age
  • Symptoms include:
    • Pain
      • Should be present for at least 3 months
      • Pain is felt in muscles and joints, but there is no underlying physical manifestation of the pain
      • Pain is likely due to aberrant neuropathic mechanism
      • Pain tends to worsen with insomnia, cold and humid weather
    • Headache
    • Fatigue
    • Non-restorative sleep
    • Cognitive dysfunction (fibro-fog)
      • Poor memory
      • Difficulty concentrating
      • Lack of clear thought
  • Commonly associated with:
    • Mood disorders
      • Anxiety and depression
    • Functional somatic syndromes (chronic conditions with no identifiable organic cause
      • IBS
      • Tension or migraine headaches
      • Chronic fatigue syndrome
    • Severe menstrual pain
    • Lower UTI symptoms
    • Tempomandbular pain

How to diagnose fibromyalgia?

  • Criteria for diagnosis
    • Diffuse body pain present for at least 3 months
    • WPI >= 7/19 and SS >= 5 OR WPI >= 3-6/19 and SS >= 9
    • Symptoms may not be better explained by another illness
  • What is WPI and SS?
    • Widespread pain index: self-reported number of areas in which pain is experienced over last 7 days (19 total areas)
      • Jaw (L, R)
      • Neck
      • Shoulder (L, R)
      • Upper arm (L, R)
      • Lower arm (L, R)
      • Chest
      • Abdomen
      • Upper back
      • Lower back
      • Hip/buttock (L, R)
      • Upper leg (L, R)
      • Lower leg (L, R)
    • Symptom severity score: 4 questions
      • Indicate level of severity from 0 to 3 for fatigue
      • Indicate level of severity from 0 to 3 for non-restorative sleep
      • Indicate level of severity from 0 to 3 for cognitive symptoms including mood and memory
      • Indicate if the patient has anywhere from no symptoms to a great deal of symptoms from 0 to 3
  • According to the most recent Canadian guidelines, the 18 tender point examination (1990) is no longer required for diagnosis
    • Traditionally, patients needed to have tenderness in 11/18 of the following areas of the body, with enough digital pressure that the thumbnail bed blanches
      • Lower anterior neck (2 points)
      • Second rib (2 points)
      • Occiput (2 points)
      • Trapezius, upper back (4 points, 2 on each side)
      • Lateral epicondyle (2 points)
      • Knees (2 points)
      • Greater trochanter (2 points)
      • Upper outer quadrant of guteal (2 points)
  • Laboratory investigations
    • No laboratory test which can confirm fibromyalgia exists presently
    • Laboratory testing is only conducted to rule out similarly presenting illnesses
      • CBC
      • ESR and CRP (inflammatory arthritis, polymyalgia rheumatica)
      • TSH (hypothyroidism)
      • CK (myopathies)

Differential diagnosis for fibromyalgia

  • Inflammatory rheumatological diseases
    • Rheumatoid arthritis
    • Inflammatory spondyloarthritis
    • Systemic lupus erythematosus
    • Polymyalgia rheumatica
    • Myositis
  • Neurological conditions
    • Multiple sclerosis
    • Neuropathies
      • Presents with more localized pain compared to FM
    • Myopathies
  • Hypothyroidism
    • Ill-defined pain and fatigue
  • Depression
    • Presents with more generalized pain compared to FM
  • Medication side effects
    • Statins
    • Aromatose inhibitors for breast cancer
    • Bisphosphonates
    • Bony metastases

Fibromyalgia vs polymyalgia rheumatica vs myositis vs. rheumatoid arthritis

Polymyalgia rheumatica

  • Inflammatory rheumatic disease
  • Associated with giant cell arteritis
  • Clinical presentation
    • Pain is not from muscle but from tissues surrounding muscle
    • This is why CK is usually normal
    • Pain and stiffness of shoulders, neck and hips
    • Improve after activity
    • Constitutional symptoms: fever, weight loss, loss of appetite, night sweats
  • Diagnosis
    • Increased ESR and CRP
    • Normal CK
    • Normochromic anemia
  • Treatment
    • Low dose oral glucocorticoids
    • Eventually taper and stop glucocorticoids if symptoms improve

Dermatomyositis and Polymyositis

  • Clinical presentation
    • Polymyositis is inflammatory myopathy causing proximal muscle weakness (pelvis and shoulder)
    • Dermatomyositis is polymyositis but also skin involvement
      • Gottron papules – erythematous papules on the dorsal surface of hand
      • Heliotrope rash – erythematous rash on upper eyelids
  • Diagnosis
    • Elevated muscle enzymes
      • Increased CK
      • Increased AST, ALT
      • Increased LDH
    • Increased ESR and CRP
    • Myositis specific antibodies (useful for determining prognosis and response to treatment)
      • Anti-Jo-1
      • Anti-Mi-2
      • Anti-SRP
    • Other tests
      • Abnormal EMG
      • Muscle biopsy
  • Treatment
    • Corticosteroids
    • Immunosuppresants

Rheumatoid arthritis

  • Inflammatory rheumatologic disease defined by joint pain
  • Clinical presentation
    • IN CONTRAST TO polymyalgia rheumatica, distal joints are more affected in RA
      • MCP
      • PIP
      • DIPs are usually spared
      • Knees
      • Wrist joints
      • Cervical spine may be affected
    • Morning stiffness of > 30 mins
    • Extra-articular manifestations include
      • Constitutional symptoms
      • Rheumatoid nodules (non-tender subcutaneous bump)
      • Pleuritis
      • Pericarditis
      • Anemia of chronic disease
  • Diagnosis
    • Using ACR criteria
    • Laboratory tests
      • Increased ESR and CRP
      • Increased ferritin
      • Anemia of chronic disease
      • Anti-CCP is very specific and moderately sensitive
      • ANA
      • Rheumatoid factor
  • Treatment
    • Methotrexate
      • First line
      • Highly effective
      • Many side effects
        • GI side effects
        • Abnormal liver enzymes due to hepatotoxicity
        • Bone marrow suppression
        • Pneumonitis and pulmonary fibrosis
        • Nephrotoxicity
      • Methotrexate is a folic acid antimetabolite – provide folate within 48 hours of starting methotrexate
    • TNFa inhibitors if severe disease remains after 3 months of methotrexate

RF is sensitive for rheumatoid arthritis (but sensitive is lower in the first few months of disease onset). Anti-CCP is specific for rheumatoid arthritis.

ANA is sensitive for SLE while anti-double stranded DNA antibodies are specific for SLE.

How to manage fibromylagia?

  • Pharmacologic treatment
    • Progression of pharmacologic treatment
      • Simple analgesics
      • TCA
        • Amitriptyline is a good TCA to start with
        • Has anticholinergic (mouth dryness, blurry vision, urinary retention, constipation) and anti-histamine (drowsiness) effects
      • SSRI, SNRI also show positive effects for pain, fatigue, depression and quality of life (pain reduction is still better for TCAs though)
        • E.g. duolextine, paroxetine, fluoxetine, sertraline
      • Pregabalin and gabapentin (anti-convulsants)
      • Opioids – last resort
        • Tramadol (weak opioid) is the only opioid that has been thoroughly studied for use in FM
        • Reserved for patients who are non-responsive to other forms of therapy
        • Avoid use of strong opioids
  • Non-pharmacologic treatment
    • Improved mental well-being is associated with reduced pain intensity in FM
      • CBT
      • Group therapy
    • Exercise
      • Aerobic exericse
      • Yoga